Deleterious protein‐altering mutations in the SCN10A voltage‐gated sodium channel gene are associated with prolonged QT

Deleterious protein‐altering mutations in the SCN10A voltage‐gated sodium channel gene are... INTRODUCTIONLong QT syndrome (LQT) is a pro‐arrhythmogenic condition that increases the risk of a unique life‐threatening polymorphic ventricular tachycardia known as “torsades de pointes,” and sudden cardiac death (SCD). Congenital LQTs are inherited disorders caused by mutations in cardiac conduction channels or associated proteins, and are estimated to affect 0.005% to 0.05% of the general population. LQT is also accounted for by QT prolonging drugs, electrolyte abnormalities, ischemic heart disease or structural heart disease; a condition that is often referred to as acquired LQT. With the advent of genome sequencing it is evident that genetic variants with small effects also account for some, if not all, subclinical acquired LQTs that manifest themselves in the presence of additional precipitating factors. It has also been estimated that 10% to 36% of patients with LQT genotypes are silent mutation carriers.To this date 15 different types of congenital LQT have been characterized and account for about 80% of inherited long QT cases. These correspond to mutations in genes encoding potassium channels, calcium channels, calcium signaling proteins, anchoring proteins, transport proteins, and voltage‐gated sodium channels. Most of these genes have been established as casual genes for LQT based on linkage or segregation analysis, or http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Clinical Genetics Wiley

Deleterious protein‐altering mutations in the SCN10A voltage‐gated sodium channel gene are associated with prolonged QT

Loading next page...
 
/lp/wiley/deleterious-protein-altering-mutations-in-the-scn10a-voltage-gated-v6Yw5rq6Bg
Publisher
Wiley
Copyright
© 2018 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd
ISSN
0009-9163
eISSN
1399-0004
D.O.I.
10.1111/cge.13036
Publisher site
See Article on Publisher Site

Abstract

INTRODUCTIONLong QT syndrome (LQT) is a pro‐arrhythmogenic condition that increases the risk of a unique life‐threatening polymorphic ventricular tachycardia known as “torsades de pointes,” and sudden cardiac death (SCD). Congenital LQTs are inherited disorders caused by mutations in cardiac conduction channels or associated proteins, and are estimated to affect 0.005% to 0.05% of the general population. LQT is also accounted for by QT prolonging drugs, electrolyte abnormalities, ischemic heart disease or structural heart disease; a condition that is often referred to as acquired LQT. With the advent of genome sequencing it is evident that genetic variants with small effects also account for some, if not all, subclinical acquired LQTs that manifest themselves in the presence of additional precipitating factors. It has also been estimated that 10% to 36% of patients with LQT genotypes are silent mutation carriers.To this date 15 different types of congenital LQT have been characterized and account for about 80% of inherited long QT cases. These correspond to mutations in genes encoding potassium channels, calcium channels, calcium signaling proteins, anchoring proteins, transport proteins, and voltage‐gated sodium channels. Most of these genes have been established as casual genes for LQT based on linkage or segregation analysis, or

Journal

Clinical GeneticsWiley

Published: Jan 1, 2018

Keywords: ; ; ; ; ;

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create lists to
organize your research

Export lists, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off